US20090142424A1 - Natural topical compositions for the prevention and treatment of diaper rashes and related conditions - Google Patents

Natural topical compositions for the prevention and treatment of diaper rashes and related conditions Download PDF

Info

Publication number
US20090142424A1
US20090142424A1 US11/999,130 US99913007A US2009142424A1 US 20090142424 A1 US20090142424 A1 US 20090142424A1 US 99913007 A US99913007 A US 99913007A US 2009142424 A1 US2009142424 A1 US 2009142424A1
Authority
US
United States
Prior art keywords
composition
cranberry
weight
anthocyanins
diaper rash
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/999,130
Inventor
Rafael Avila
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natural Organics Inc
Original Assignee
Natural Organics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natural Organics Inc filed Critical Natural Organics Inc
Priority to US11/999,130 priority Critical patent/US20090142424A1/en
Assigned to NATURAL ORGANICS, INC. reassignment NATURAL ORGANICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AVILA, RAFAEL
Publication of US20090142424A1 publication Critical patent/US20090142424A1/en
Priority to US12/455,726 priority patent/US7799355B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • This invention relates to topical compositions for the treatment of skin irritation and, more particularly, to anthocyanin-containing compositions for the treatment of diaper rash.
  • Diaper rash also referred to as diaper dermatitis or incontinence dermatitis
  • Diaper rash is a generic term applied to rashes seen in the diaper area (genital, buttocks and thighs, or any area of skin that is covered by a diaper-like dressing) that may be caused by a variety of skin disorders.
  • Diaper dermatitis develops when skin is exposed to prolonged wetness, increased skin pH caused by urine and feces, with the resulting breakdown of the stratum corneum, or outermost layer of the skin. In adults, the stratum corneum is composed of 25 to 30 layers of flattened dead keratinocytes, which are continuously shed and replaced from below.
  • Cranberry hereinafter encompass cranberry, cranberry extract, cranberry concentrate, cranberry juice, cranberry juice concentrates, in all forms, including by way of examples and not by way of limitation, liquid, solid, powdered, dehydrated, or extracted using any of the currently available production methods.
  • the present invention addresses a number of problems associated with previously known diaper rash treatments by providing compositions which include anthocyanins which contribute to the treatment and/or prevention of diaper rash. While previous treatments and compositions required multiple ingredients to achieve a) a reduction of pH, b) a reduction of moisture and c) a reduction of irritant microbes and/or irritant microbial byproducts, the inclusion of at least one anthocyanin in the composition of the present invention achieves all of these objectives. And given that vaccinium macrocarpon known colloquially as cranberry, which contains the preferred anthocyanins for use in the present invention is widely abundant and inexpensive, the present invention, achieves the aforementioned objectives in a very cost-effective manner.
  • the present invention is primarily intended for use on or around the affected skin of the diaper area in both infants and toddlers and incontinent adults. This includes, but is not limited to, the buttocks, genitals, lower abdomen and the thigh folds.
  • Cranberry and/or cranberry extract is naturally acidic and therefore naturally helps to lower skin pH. Cranberry has also been found to contain as much as 12% fiber (DUKE1992A), and is a known moisture adsorbent. And, most importantly, numerous studies (Di Martino et al. 2006, Firon et al. 1987; Jepson et al. 2004; Howell et al. 2005; Raz et al. 2004; Tsukada et al. 1994; Turner et al. 2005; Zafriri et al., 1989; Zhang et al. 2005) have shown that cranberry and/or cranberry extracts inhibit the adhesion of yeast and bacteria to epithelial surfaces.
  • cranberry and/or cranberry extract contributes many attributes, which effectively combat many of the causal factors of diaper rash.
  • the present invention includes all known topical delivery media or mechanisms, including by way of example, and not by way of limitation, lotions, creams, ointments, sprays, dressings, or other methods of topical application. Exemplary thereof would be any of the known ointment or lotion media with a low level of skin irritation.
  • the present invention may include cranberry alone, or it may include cranberry as part of a more comprehensive formulation, including other ingredients.
  • the following formulation is a representative embodiment of such other ingredients and it is not intended to limit the scope of the invention.
  • Zinc oxide (Functions as a barrier material);
  • cod liver oil skin conditioning agent-source of vitamins A and D
  • lanolin skin conditioning agent
  • petrolatum functions as a barrier material
  • the present invention incorporates a concentration of at least about 16 ppb of cranberry—or other vaccinium-derived anthocyanins.
  • concentrations up to about 50% by weight of the composition, can be employed advantageously with the upper limit being dictated by the benefit realized to the patient.
  • Cranberry anthocyanins commonly occur in cranberry fruit and juice in the range of 18 mg per 100 g, or 0.018% (Zhou and Singh, 2004).
  • a medium containing 11.25 parts per million (0.001%) cranberry fruit or cranberry juice will contain 16 ppb of cranberry anthocyanins, and thus contain a concentration of cranberry anthocyanins sufficient to impart anti-adhesion microbial activity.
  • acne actinic keratosis, athlete's foot, aquagenic pruritus, atopic dermatitis, bed sore, Behcet's disease, blepharitis, boils, Bowen's disease, bullous pemphigoid, canker sore, carbuncles, cellulitis, chloracne, chronic dermatitis of the hands and feet, cold sores, contact dermatitis, creeping eruption, dandruff, dermatitis, dermatitis herpetiformis, diaper rash, dyshidrosis, eczema, epidermolysis bullosa, erysipelas, erythroderma, Ferguson's disease, friction blister, hidradenitis suppurativa, hyperhidrosis, ichthyosis, impetigo, jock itch, keloid, keratosis pilaris, lichen planus, lichen simplex chronicus, lymphadenitis, melasm
  • Preferred embodiments of the invention are described in the form of a cream, a powder and a baby wipe, with the percentage of ingredients present being listed in descending order from the highest to the lowest.
  • cranberry extract is included at 0.01%, by weight, of the total composition.
  • Zinc Oxide included at 10% by weight
  • Beeswax Benzyl Alcohol
  • coconut Oil Cod liver Oil
  • Dimethicone Fragrance
  • Glyceryl Oleate Mineral Oil
  • Ozokerite Paraffin
  • Propylene Glycol Purified Water, Red Ferric Oxide, Sorbitol, cranberry extract ( Vaccinium macrocarpon fruit extract containing 0.2-0.8% anthocyanins, and/or related anthocyanosides).
  • Corn starch corn starch, zinc oxide (included at 10% by weight), ferric oxide, fragrance, cranberry extract ( Vaccinium magrocarpon fruit extract containing 0.2-0.8% anthocyanins, and/or related anthocyanosides), tricalcium phosphate.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Absorbent Articles And Supports Therefor (AREA)

Abstract

The treatment and prevention of skin irritations, including diaper rash, is facilitated with the topical application of cranberry anthocyanins in a cosmetically acceptable vehicle.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • This invention relates to topical compositions for the treatment of skin irritation and, more particularly, to anthocyanin-containing compositions for the treatment of diaper rash.
  • 2. Background of the Invention and Related Art
  • Diaper rash (also referred to as diaper dermatitis or incontinence dermatitis) is a generic term applied to rashes seen in the diaper area (genital, buttocks and thighs, or any area of skin that is covered by a diaper-like dressing) that may be caused by a variety of skin disorders. Diaper dermatitis develops when skin is exposed to prolonged wetness, increased skin pH caused by urine and feces, with the resulting breakdown of the stratum corneum, or outermost layer of the skin. In adults, the stratum corneum is composed of 25 to 30 layers of flattened dead keratinocytes, which are continuously shed and replaced from below. These dead cells are interlayered with lipids secreted by the stratum granulosum just underneath, which help to make this layer of the skin a waterproof barrier. The stratum corneum's function is to reduce water loss, repel water, protect deeper layers of the skin from injury and to repel microbial invasion of the skin. In infants, this layer of the skin is much thinner and more easily disrupted.
  • It is generally accepted that various combinations of factors, and not a single causative factor, causes diaper rash. However, certain factors appear to be far more prevalent as causal agents than others. The most prominent factors are ammonia from urine and its increase of the pH of the skin, bacterial growth and the metabolic byproducts of such growth, yeast growth, including Candida albicans, and their metabolic byproducts, and excess moisture.
  • The use of herbal remedies and ointments for the soothing or treatment of diaper rashes is known in the prior art. For example, U.S. Pat. No. 6,627,178, the disclosure of which is incorporated herein by reference, discloses an ointment composition containing calendula, chamomile and/or comfrey for the treatment of diaper rashes. Another example of the use of herbal remedies in ointments for the treatment of diaper rashes is U.S. Pat. No. 6,419,963, the disclosure of which is incorporated herein by reference, which discloses a composition containing beeswax, olive oil, beta-sitosterol and the herb Coptis chinensis Franch.
  • However, neither of the aforementioned patents yield the benefits achieved by the current invention, which provides an economical, all-natural product that provides relief from diaper rash, as well as other skin irritations.
  • All references to “Cranberry” hereinafter encompass cranberry, cranberry extract, cranberry concentrate, cranberry juice, cranberry juice concentrates, in all forms, including by way of examples and not by way of limitation, liquid, solid, powdered, dehydrated, or extracted using any of the currently available production methods.
  • SUMMARY OF THE INVENTION
  • The present invention addresses a number of problems associated with previously known diaper rash treatments by providing compositions which include anthocyanins which contribute to the treatment and/or prevention of diaper rash. While previous treatments and compositions required multiple ingredients to achieve a) a reduction of pH, b) a reduction of moisture and c) a reduction of irritant microbes and/or irritant microbial byproducts, the inclusion of at least one anthocyanin in the composition of the present invention achieves all of these objectives. And given that vaccinium macrocarpon known colloquially as cranberry, which contains the preferred anthocyanins for use in the present invention is widely abundant and inexpensive, the present invention, achieves the aforementioned objectives in a very cost-effective manner.
  • The present invention is primarily intended for use on or around the affected skin of the diaper area in both infants and toddlers and incontinent adults. This includes, but is not limited to, the buttocks, genitals, lower abdomen and the thigh folds.
  • Cranberry and/or cranberry extract is naturally acidic and therefore naturally helps to lower skin pH. Cranberry has also been found to contain as much as 12% fiber (DUKE1992A), and is a known moisture adsorbent. And, most importantly, numerous studies (Di Martino et al. 2006, Firon et al. 1987; Jepson et al. 2004; Howell et al. 2005; Raz et al. 2004; Tsukada et al. 1994; Turner et al. 2005; Zafriri et al., 1989; Zhang et al. 2005) have shown that cranberry and/or cranberry extracts inhibit the adhesion of yeast and bacteria to epithelial surfaces. Such inhibition of adhesion inhibits the growth of yeast and bacteria (as well as other microorganisms). With reduced adhesive capacity, microorganisms are more easily removed through common practices of diaper changing, wiping and general good hygiene. Thus, cranberry and/or cranberry extract contributes many attributes, which effectively combat many of the causal factors of diaper rash.
  • The present invention includes all known topical delivery media or mechanisms, including by way of example, and not by way of limitation, lotions, creams, ointments, sprays, dressings, or other methods of topical application. Exemplary thereof would be any of the known ointment or lotion media with a low level of skin irritation.
  • The present invention may include cranberry alone, or it may include cranberry as part of a more comprehensive formulation, including other ingredients. The following formulation is a representative embodiment of such other ingredients and it is not intended to limit the scope of the invention.
  • Zinc oxide (Functions as a barrier material);
  • cod liver oil (skin conditioning agent-source of vitamins A and D);
  • lavender (Fragrance);
  • chamomile (Fragrance);
  • natural vitamin E (skin conditioning agent);
  • lanolin (skin conditioning agent);
  • fragrance
  • petrolatum (functions as a barrier material);
  • talc; and
  • purified water.
  • The present invention incorporates a concentration of at least about 16 ppb of cranberry—or other vaccinium-derived anthocyanins. The use of higher concentrations, up to about 50% by weight of the composition, can be employed advantageously with the upper limit being dictated by the benefit realized to the patient.
  • It has been found that it is primarily the proanthocyanins and anthocyanins in vaccinium genus, including cranberry (Vaccinium macrocarpon), that impart the anti-microbial-adhesion activity. Accordingly, juices, concentrates, and extracts from all members of the vaccinium genus can be employed to advantage, with cranberry being preferred.
  • Cranberry anthocyanins commonly occur in cranberry fruit and juice in the range of 18 mg per 100 g, or 0.018% (Zhou and Singh, 2004). A medium containing 11.25 parts per million (0.001%) cranberry fruit or cranberry juice will contain 16 ppb of cranberry anthocyanins, and thus contain a concentration of cranberry anthocyanins sufficient to impart anti-adhesion microbial activity.
  • Although the aforesaid embodiment of this invention focuses on diaper rash, it may also be used to advantage in the treatment of any of the following conditions as they may relate to, or be exacerbated by, bacterial adhesion:
  • acne, actinic keratosis, athlete's foot, aquagenic pruritus, atopic dermatitis, bed sore, Behcet's disease, blepharitis, boils, Bowen's disease, bullous pemphigoid, canker sore, carbuncles, cellulitis, chloracne, chronic dermatitis of the hands and feet, cold sores, contact dermatitis, creeping eruption, dandruff, dermatitis, dermatitis herpetiformis, diaper rash, dyshidrosis, eczema, epidermolysis bullosa, erysipelas, erythroderma, Ferguson's disease, friction blister, hidradenitis suppurativa, hyperhidrosis, ichthyosis, impetigo, jock itch, keloid, keratosis pilaris, lichen planus, lichen simplex chronicus, lymphadenitis, melasma, miliaria, molluscum contagiosum, nummular dermatitis, pediculosis, pemphigus, perioral dermatitis, photoallergy, photosensitivity, pityriasis rosea, pityriasis rubra pilaris, porphyria, psoriasis, Raynaud's disease, ringworm, rosacea, scabies, scleroderma, sebaceous cyst, seborrheic keratosis, seborrhoeic dermatitis, shingles, skin tags, spider veins, stasis dermatitis, tinea barbae, tinea capitis, tinea corporis, tinea cruris, tinea pedis, tinea unguium, tinea versicolor, tinea, tungiasis, urticaria, and warts.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Preferred embodiments of the invention are described in the form of a cream, a powder and a baby wipe, with the percentage of ingredients present being listed in descending order from the highest to the lowest. In each embodiment, cranberry extract is included at 0.01%, by weight, of the total composition.
  • Cream Form
  • Aloe Barbadensis Leaf Juice, Zinc Oxide (included at 10% by weight), Beeswax, Benzyl Alcohol, Coconut Oil, Cod liver Oil, Dimethicone, Fragrance, Glyceryl Oleate, Mineral Oil, Ozokerite, Paraffin, Propylene Glycol, Purified Water, Red Ferric Oxide, Sorbitol, cranberry extract (Vaccinium macrocarpon fruit extract containing 0.2-0.8% anthocyanins, and/or related anthocyanosides).
  • Powder Form
  • Corn starch, zinc oxide (included at 10% by weight), ferric oxide, fragrance, cranberry extract (Vaccinium magrocarpon fruit extract containing 0.2-0.8% anthocyanins, and/or related anthocyanosides), tricalcium phosphate.
  • Disposable Baby Wipe Form
  • Water, Glycerin, Aloe Vera, Tocopheryl Acetate (Vitamin E), Polysorbate 20, Cranberry Extract, Potassium Sorbate, Tartaric Acid, Fragrance.
  • Accordingly, it will be appreciated that the present invention has been described with reference to particular preferred embodiments that are now contemplated. However, the invention is not limited to the embodiments disclosed herein and it will be appreciated that numerous modifications and other embodiments may be devised by those skilled in the art. Therefore, it is intended that the appended claims cover all such modifications and embodiments that fall within the spirit and scope of the present invention.

Claims (15)

1. A composition for treating or preventing skin irritation in humans, which comprises:
a) cranberry anthocyanins; and
b) a cosmetically acceptable vehicle or carrier.
2. The composition of claim 1 wherein the cosmetically acceptable vehicle is the form of a powder, concentrate, extract, lotion, cream, ointment or spray.
3. The composition of claim 2 wherein the vehicle is a powder containing from about 16.25 parts per billion to 50%, by weight, of cranberry anthocyanins based on the total weight of the composition.
4. The composition of claim 1, wherein the vehicle also contains zinc oxide.
5. The composition of claim 1, wherein the skin irritation is diaper rash.
6. The composition of claim 1, and including corn starch, about 10% by weight, of zinc oxide, ferric oxide, and cranberry extract containing about 0.2% to about 0.8%, by weight, of cranberry anthocyanins and tricalcium phosphate.
7. The composition of claim 1 and including aloe barbadensis leaf juice, about 10%, by weight, of zinc oxide, bees wax, benzyl alcohol, coconut oil, cod liver oil, dimethicone, glyceryl deate, mineral oil, ozokerite, paraffin, propylene glycol, purified water, red ferric oxide, sorbitol and cranberry extract containing about 0.2% to about 0.8%, by weight, of cranberry anthocyanins.
8. The composition of claim 1, and including, water, glycerin, aloe vera, vitamin E, polysorbate 20, cranberry extract containing about 0.2% to 0.8%, by weight, of cranberry anthocyanins, potassium sorbate and tartaric acid.
9. A method for treating or preventing skin irritation in humans, which comprises applying a composition including a cranberry anthocyanin in a cosmetically acceptable vehicle or carrier to an irritated skin surface in a quantity sufficient to form a coating thereon.
10. The method of claim 9, wherein the skin irritation is diaper rash.
11. The method of claim 9, wherein the cosmetically acceptable vehicle is in the form of a powder, concentrate, extract, lotion, cream, ointment or spray.
12. The method of claim 11, wherein the vehicle is a powder containing from about 16 parts per billion to about 50% by weight of cranberry anthocyanins based on the total weight of the composition.
13. A powder for treating diaper rash in accordance with the composition of claim 6.
14. A cream for treating diaper rash in accordance with the composition of claim 7.
15. A wipe for treating diaper rash in accordance with the composition of claim 8.
US11/999,130 2006-12-04 2007-12-03 Natural topical compositions for the prevention and treatment of diaper rashes and related conditions Abandoned US20090142424A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US11/999,130 US20090142424A1 (en) 2007-12-03 2007-12-03 Natural topical compositions for the prevention and treatment of diaper rashes and related conditions
US12/455,726 US7799355B2 (en) 2006-12-04 2009-06-05 Natural topical compositions for the prevention and treatment of diaper rashes and related conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/999,130 US20090142424A1 (en) 2007-12-03 2007-12-03 Natural topical compositions for the prevention and treatment of diaper rashes and related conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/455,726 Division US7799355B2 (en) 2006-12-04 2009-06-05 Natural topical compositions for the prevention and treatment of diaper rashes and related conditions

Publications (1)

Publication Number Publication Date
US20090142424A1 true US20090142424A1 (en) 2009-06-04

Family

ID=40675974

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/999,130 Abandoned US20090142424A1 (en) 2006-12-04 2007-12-03 Natural topical compositions for the prevention and treatment of diaper rashes and related conditions
US12/455,726 Expired - Fee Related US7799355B2 (en) 2006-12-04 2009-06-05 Natural topical compositions for the prevention and treatment of diaper rashes and related conditions

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/455,726 Expired - Fee Related US7799355B2 (en) 2006-12-04 2009-06-05 Natural topical compositions for the prevention and treatment of diaper rashes and related conditions

Country Status (1)

Country Link
US (2) US20090142424A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103877381A (en) * 2014-03-23 2014-06-25 霍焕民 Traditional Chinese medicine for treating goose-skinned palm
WO2020225202A1 (en) * 2019-05-03 2020-11-12 Anklam Extrakt Gmbh Maqui berry extracts for treatment of skin diseases

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9526783B1 (en) * 2014-12-05 2016-12-27 C.B. Fleet Company Incorporated Spray composition for treating and preventing diaper rash

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589537B2 (en) * 1999-02-11 2003-07-08 Marie Harbeck Infant skin care composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3636973B2 (en) * 2000-06-26 2005-04-06 株式会社カネボウ化粧品 Radical scavengers and cosmetics
US20040109905A1 (en) * 2002-09-18 2004-06-10 Debasis Bagchi Method and composition of anthocyanin-rich berry extracts that prevents or inhibits angiogenesis and helicobacter pylori and acts as a powerful antioxidant that provides various health benefits

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589537B2 (en) * 1999-02-11 2003-07-08 Marie Harbeck Infant skin care composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103877381A (en) * 2014-03-23 2014-06-25 霍焕民 Traditional Chinese medicine for treating goose-skinned palm
WO2020225202A1 (en) * 2019-05-03 2020-11-12 Anklam Extrakt Gmbh Maqui berry extracts for treatment of skin diseases

Also Published As

Publication number Publication date
US7799355B2 (en) 2010-09-21
US20090247622A1 (en) 2009-10-01

Similar Documents

Publication Publication Date Title
KR20030047993A (en) Antipruritic compositions and compositions promoting wound healing
WO2008140200A1 (en) External compositions for the skin
KR101338681B1 (en) Health food or pharmaceutical composition comprising chestnut shell extract
EP1940432B1 (en) Anti-inflammatory compositions and methods of use
US8697152B2 (en) Anti-inflammatory compositions and personal care compositions comprising olive leaf (Olea europea) extract
US20210346276A1 (en) Skincare compositions containing cannabidiol
US7799355B2 (en) Natural topical compositions for the prevention and treatment of diaper rashes and related conditions
US10500187B2 (en) Composition comprising plant phenols for preventing or reducing TEWL and associated disorders and diseases
KR20020076375A (en) Cosmetics Useful for atopic skin
EP2566455B1 (en) Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies
US20160129063A1 (en) Composition for topical use in prevention and treatment of bacterial and fungal infections of skin and mucosa
JP6951592B2 (en) Compositions for the prevention or treatment of skin infections
Wijayadi et al. The Role of Essential Oils on Improving Elderly Skin Hydration
KR101140573B1 (en) External Skin Preparation Using an Extract of Horse Plancenta
CN112870269B (en) Natural galenical composition with antibacterial, bactericidal and eczema treating effects
KR20080018624A (en) Use of an extract of organic selenium-enriched and sprouted bean
CN113713018A (en) Traditional Chinese medicine composition of eczema ointment and preparation process thereof
US9421161B2 (en) Herbal composition and a method of making thereof
CN107683144B (en) Combination of at least one protease inhibitor and at least one active ingredient for use in the prevention and/or treatment of skin lesions
KR102676584B1 (en) Composition for improving and treating allergy comprising active ingredient from guava and green tea leaf extract complex
CN115844784B (en) Composition for relieving inflammation of dry skin and application and preparation method thereof
KR102650364B1 (en) Composition for anti-oxidation, anti-inflammation, anti-atopy, anti-wrinkle and improvement of moisturizing comprising extract of Lycorisradiata
KR20050118820A (en) The composition having the prevention of atopy
US20220071922A1 (en) Delivery of health benefits through component formulation
CN112386539A (en) Shampoo product with effects of recovering scalp itching and desquamation

Legal Events

Date Code Title Description
AS Assignment

Owner name: NATURAL ORGANICS, INC., NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AVILA, RAFAEL;REEL/FRAME:020251/0271

Effective date: 20071203

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION